Tango Therapeutics, Inc. (TNGX)
9.17
+0.05
(+0.55%)
USD |
NASDAQ |
Dec 10, 16:00
9.17
0.00 (0.00%)
After-Hours: 20:00
Tango Therapeutics Shareholders Equity (Quarterly): 160.03M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| XOMA Royalty Corp. | 107.96M |
| Viking Therapeutics, Inc. | 713.03M |
| Avanos Medical, Inc. | 778.00M |
| Krystal Biotech, Inc. | 1.138B |
| Moderna, Inc. | 9.33B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 210.14M |
| Total Liabilities (Quarterly) | 50.10M |
| Debt to Equity Ratio | 0.2172 |
| Current Ratio | 8.880 |
| Net Debt Paydown Yield | 0.07% |